Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (441-450 of 568) with videos related to

Pageof 57
Sort By:
Alimentary Pharmacology & Therapeutics|March 18, 2020
Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel diseaseIago Rodríguez-Lago, Jesús Castro-Poceiro, Agnès Fernández-Clotet, et al.
Journal of Clinical Gastroenterology|January 6, 2021
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Bojan Tepes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 2, 2021
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 StudiesRenske W M Pauwels, C Janneke van der Woude, Daan Nieboer, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Human Molecular Genetics|August 2, 2014
A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitisAntonio Julià, Eugeni Domènech, María Chaparro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2016
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agentMaría Del Carmen R-Grau, María Chaparro, Francisco Mesonero, et al.
Frontiers in Immunology|October 10, 2022
Experimental and genetic evidence for the impact of <i>CD5</i> and <i>CD6</i> expression and variation in inflammatory bowel diseaseSergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2026
Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World PracticeDuc Trong Quach, Jyh-Ming Liou, Javier P Gisbert, et al.
International Journal of Cancer|September 2, 2018
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14Osmel Companioni, Catalina Bonet, Nadia García, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Pageof 57

Showing results (441-450 of 568) with videos related to

Sort By:
Pageof 57
Alimentary Pharmacology & Therapeutics|March 18, 2020
Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel diseaseIago Rodríguez-Lago, Jesús Castro-Poceiro, Agnès Fernández-Clotet, et al.
Journal of Clinical Gastroenterology|January 6, 2021
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Bojan Tepes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 2, 2021
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 StudiesRenske W M Pauwels, C Janneke van der Woude, Daan Nieboer, et al.
United European Gastroenterology Journal|November 12, 2020
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practiceOlga P Nyssen, Angeles Perez-Aisa, Manuel Castro-Fernandez, et al.
Human Molecular Genetics|August 2, 2014
A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitisAntonio Julià, Eugeni Domènech, María Chaparro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2016
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agentMaría Del Carmen R-Grau, María Chaparro, Francisco Mesonero, et al.
Frontiers in Immunology|October 10, 2022
Experimental and genetic evidence for the impact of <i>CD5</i> and <i>CD6</i> expression and variation in inflammatory bowel diseaseSergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2026
Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World PracticeDuc Trong Quach, Jyh-Ming Liou, Javier P Gisbert, et al.
International Journal of Cancer|September 2, 2018
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14Osmel Companioni, Catalina Bonet, Nadia García, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Pageof 57